Atlas Arteria
Market Cap
AU$6.3b
Last Updated
2020/12/02 07:07 UTC
Data Sources
Company Financials +
Executive Summary
Atlas Arteria Limited owns, develops, and operates toll roads. More Details
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential and slightly overvalued.
Similar Companies
Share Price & News
How has Atlas Arteria's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ALX is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: ALX's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
-3.4%
ALX
-3.1%
AU Infrastructure
-1.1%
AU Market
1 Year Return
-12.7%
ALX
-6.4%
AU Infrastructure
1.7%
AU Market
Return vs Industry: ALX underperformed the Australian Infrastructure industry which returned -8% over the past year.
Return vs Market: ALX underperformed the Australian Market which returned 0% over the past year.
Shareholder returns
| ALX | Industry | Market | |
|---|---|---|---|
| 7 Day | -3.4% | -3.1% | -1.1% |
| 30 Day | 16.2% | 7.5% | 10.8% |
| 90 Day | -2.4% | -1.3% | 8.1% |
| 1 Year | -11.1%-12.7% | -3.3%-6.4% | 5.2%1.7% |
| 3 Year | 22.1%9.0% | 27.8%12.1% | 24.1%8.7% |
| 5 Year | 86.6%53.3% | 72.8%39.4% | 58.8%26.5% |
Long-Term Price Volatility Vs. Market
How volatile is Atlas Arteria's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?1 month ago | Simply Wall St
Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 69% Return On Their Investment1 month ago | Simply Wall St
Need To Know: Atlas Arteria Limited (ASX:ALX) Insiders Have Been Buying SharesValuation
Is Atlas Arteria undervalued compared to its fair value and its price relative to the market?
38.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ALX (A$6.53) is trading below our estimate of fair value (A$10.56)
Significantly Below Fair Value: ALX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ALX is unprofitable, so we can't compare its PE Ratio to the XO Infrastructure industry average.
PE vs Market: ALX is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ALX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ALX's PB Ratio (1.6x) is in line with the AU Infrastructure industry average.
Next Steps
Future Growth
How is Atlas Arteria forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
67.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: ALX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALX's is expected to become profitable in the next 3 years.
Revenue vs Market: ALX's revenue (10.2% per year) is forecast to grow faster than the Australian market (5.1% per year).
High Growth Revenue: ALX's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALX's Return on Equity is forecast to be low in 3 years time (9.8%).
Next Steps
Past Performance
How has Atlas Arteria performed over the past 5 years?
-20.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ALX is currently unprofitable.
Growing Profit Margin: ALX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ALX is unprofitable, and losses have increased over the past 5 years at a rate of 20.3% per year.
Accelerating Growth: Unable to compare ALX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALX is unprofitable, making it difficult to compare its past year earnings growth to the Infrastructure industry (-22.4%).
Return on Equity
High ROE: ALX has a negative Return on Equity (-1.21%), as it is currently unprofitable.
Next Steps
Financial Health
How is Atlas Arteria's financial position?
Financial Position Analysis
Short Term Liabilities: ALX's short term assets (A$194.6M) exceed its short term liabilities (A$84.4M).
Long Term Liabilities: ALX's short term assets (A$194.6M) do not cover its long term liabilities (A$1.7B).
Debt to Equity History and Analysis
Debt Level: ALX's debt to equity ratio (43.7%) is considered high.
Reducing Debt: Insufficient data to determine if ALX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: ALX's debt is not well covered by operating cash flow (3.9%).
Interest Coverage: Insufficient data to determine if ALX's interest payments on its debt are well covered by EBIT.
Balance Sheet
Next Steps
Dividend
What is Atlas Arteria current dividend yield, its reliability and sustainability?
4.83%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ALX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ALX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ALX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ALX is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ALX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.7yrs
Average management tenure
CEO
Graeme Bevans (62 yo)
1.67yrs
Tenure
AU$2,747,183
Compensation
Mr. Graeme Francis Bevans serves as Managing Director, Chief Executive Officer and Director at Atlas Arteria Limited since April 1, 2019. Mr. Bevans was a Partner at Alinda Capital Partners LLC since 2010....
CEO Compensation Analysis
Compensation vs Market: Graeme's total compensation ($USD2.02M) is about average for companies of similar size in the Australian market ($USD1.88M).
Compensation vs Earnings: Graeme's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 1.67yrs | AU$2.75m | 0.016% A$ 1.0m | |
| Chief Financial Officer | 1.67yrs | AU$1.15m | 0.0022% A$ 136.1k | |
| Chief Operating Officer | 1.67yrs | AU$1.10m | 0.00059% A$ 37.2k | |
| Head of Investor Relations | no data | no data | no data | |
| Company Secretary & General Counsel | 1.67yrs | no data | no data | |
| Public Affairs Manager | no data | no data | no data |
1.7yrs
Average Tenure
Experienced Management: ALX's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 1.67yrs | AU$2.75m | 0.016% A$ 1.0m | |
| Independent Non-Executive Director | 2.08yrs | AU$185.00k | 0.0031% A$ 197.8k | |
| Independent Non Executive Director | 2.17yrs | AU$187.50k | 0.0026% A$ 165.7k | |
| Independent Chairman of the Board | 0.083yr | AU$207.50k | 0.0034% A$ 216.1k |
1.9yrs
Average Tenure
60.5yo
Average Age
Experienced Board: ALX's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ALX insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 40.3%.
Top Shareholders
Company Information
Atlas Arteria Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Atlas Arteria Limited
- Ticker: ALX
- Exchange: ASX
- Founded: 2009
- Industry: Highways and Railtracks
- Sector: Transportation
- Market Cap: AU$6.301b
- Shares outstanding: 959.02m
- Website: https://www.atlasarteria.com
Location
- Atlas Arteria Limited
- 141 Flinders Lane
- Level 5
- Melbourne
- Victoria
- 3000
- Australia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ALX | ASX (Australian Securities Exchange) | Yes | Stapled Securities | AU | AUD | Jan 2010 |
| M82 | DB (Deutsche Boerse AG) | Yes | Stapled Securities | DE | EUR | Jan 2010 |
| MAQA.F | OTCPK (Pink Sheets LLC) | Yes | Stapled Securities | US | USD | Jan 2010 |
| ALX | CHIA (Chi-X Australia) | Yes | Stapled Securities | AU | AUD | Jan 2010 |
Biography
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in TRIP II, the concessionaire for Dulles Greenway toll road located in northern Virginia, the United States. The co...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/12/02 07:07 |
| End of Day Share Price | 2020/12/02 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.